No Handouts for Drug Advertisements Act

# No Handouts for Drug Advertisements Act (HR 3010) Summary **What the Bill Would Do** This bill aims to restrict government funding for pharmaceutical advertising. While specific details aren't available in the summary provided, the bill's title suggests it would prevent taxpayer money from being used to advertise prescription drugs or medications. This would primarily affect how federal health agencies and programs allocate their budgets. **Who It Affects** The bill would impact pharmaceutical companies that receive government advertising support, federal health agencies that currently fund drug promotion, and potentially patients who rely on government-provided health information about medications. Taxpayers would be affected as it relates to how federal dollars are spent. **Current Status** HR 3010 is currently in committee, meaning it has been introduced but has not yet advanced to a full vote in the House of Representatives.

The bill was sponsored by Rep. Gregory Murphy (R-NC). *Note: Limited information is publicly available about the specific provisions of this bill. For detailed language and impacts, you can review the full text on Congress.gov.*.